MedPath

Cognitive-motor Training for PD

Not Applicable
Conditions
Parkinson's Disease
Interventions
Behavioral: Identification of at risk variables
Behavioral: Gait-cognitive training
Registration Number
NCT01917903
Lead Sponsor
Stony Brook University
Brief Summary

This study will evaluate gait when individuals with Parkinson's disease (PD) are walking and how walking changes when challenged to perform a functional cognitive task simultaneously. By looking at walking alone and walking with varying cognitive loads the investigators will be able to determine motor and cognitive factors vulnerable to interference in PD. Each is important to understand so that training can address components of walking that become impaired when someone is distracted by a common cognitive task and so that the intensity of treatment matches the level of task difficulty. Using this initial data, the investigators will establish a protocol to improve walking taking into account the unique features of PD, including bradykinesia, freezing of gait, stiffness, and problems with memory and attention. The investigators will evaluate the potential for this treatment to improve walking and improve or maintain cognitive abilities necessary to multitask.

Detailed Description

In this study participants will be asked to participate in a training study to examine whether a new walking intervention that combines cognitive training with walking on a treadmill improves walking more than gait training or cognitive training alone. Participants with Parkinson's disease (PD) will come to the lab for a complete gait assessment using a motion analysis system that will record leg motion and muscle activity during comfortable walking. During the initial evaluation, participants will also complete cognitive assessments and surveys about community activities and quality of life related to PD. Participants will be divided into two training groups and asked to come to the lab three times a week for four weeks during the intervention. One week and one month after training, participants will return to the lab to complete all the same assessments that were performed during the initial visit. The results of the three testing sessions (initial, one week and one month) will be compared between and within groups to see if any of the interventions provided unique benefits to the health of persons with PD.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Clinical diagnosis of Parkinson's disease with our without cognitive impairment
  • ambulatory for at least 200 feet without an assistive device (cane, walker, etc)
Exclusion Criteria
  • recent orthopedic injury (e.g., fracture, sprain, muscle pull, herniated disc)
  • concurrent neurological illnesses including stroke, brain cancer, spinal cord injury, and diabetic neuropathies.
  • cardiac insufficiency limiting ability to participate in walking study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Identification of at risk variablesIdentification of at risk variablesIndividuals will come in for a single visit to perform all tasks / conditions. Measurements will be taken of spatial and temporal features of walking with and without a secondary task. In addition, cognitive tests of memory and attention will be performed. Outcomes will narrow measures to those most likely to show clinically significant change.
Gait-Cognitive trainingGait-cognitive trainingParticipants will engage in a four week treadmill training program with a secondary cognitive component aimed at improving both walking and multitasking.
Primary Outcome Measures
NameTimeMethod
Spatiotemporal measures of gait across conditions and over time.Baseline testing at day one of study; follow-up testing at three time periods: 4-5 weeks after baseline (immediate post-training); 5-6 weeks (one week post-training); and 9-10 weeks after baseline (one month post-training)

Changes in gait parameters are a key measure of the difficulty of performing two tasks at once. Decreases in gait speed, increased time in double support (two feet on the ground) and stopping while talking have been linked to increased disability and risk for falls.

Secondary Outcome Measures
NameTimeMethod
Changes in cognitive performance measured with serial sevens.Baseline (day one); week 4-5 (immediate post 4 week training program); 5-6 weeks (one-week post-training); 9-10 weeks (one month post-training)

Participants will count backward by sevens from a digit between 90 and 100. The ability to perform the task will be used as a measure of cognitive trade-off relative to walking performance.

Trial Locations

Locations (1)

Stony Brook University RRAMP Laboratory

🇺🇸

Stony Brook, New York, United States

© Copyright 2025. All Rights Reserved by MedPath